Figure 2
Transcriptome stability of regulatory T cells in SCT patients. Three-dimensional principal component analysis of the primary Treg transcriptome study and resulting 6 transcriptomes. Closely related transcriptomes are marked by loops. no GVHD d90 indicates Treg transcriptome analyzed on day 90 after SCT of patients with and without developing a GVHD; no GVHD d150, Treg transcriptome analyzed on day 150 after SCT of patients (without) developing a GVHD; aGVHD manif, Treg transcriptome of GVHD patients analyzed at the time point of clinical manifestation of the acute form of GVHD; and cGVHD manif, Treg transcriptome of GVHD patients analyzed at the time point of clinical manifestation of the chronic form of GVHD.

Transcriptome stability of regulatory T cells in SCT patients. Three-dimensional principal component analysis of the primary Treg transcriptome study and resulting 6 transcriptomes. Closely related transcriptomes are marked by loops. no GVHD d90 indicates Treg transcriptome analyzed on day 90 after SCT of patients with and without developing a GVHD; no GVHD d150, Treg transcriptome analyzed on day 150 after SCT of patients (without) developing a GVHD; aGVHD manif, Treg transcriptome of GVHD patients analyzed at the time point of clinical manifestation of the acute form of GVHD; and cGVHD manif, Treg transcriptome of GVHD patients analyzed at the time point of clinical manifestation of the chronic form of GVHD.

Close Modal

or Create an Account

Close Modal
Close Modal